UnitedHealth is set to release its third-quarter 2020 financial results before the market opens on Wednesday, Oct. 14. Let’s look at analysts’ expectations for the third quarter.
When is UnitedHealth’s earnings date?
UnitedHealth plans to release its third-quarter financial results tomorrow before the market opens. The company has scheduled a conference call with analysts and investors on the same day, at 8:45 a.m. ET. In the third quarter, Wall Street analysts expect UnitedHealth to report revenue of $64.0 billion, which would be 6 percent higher than UnitedHealth's $60.4 billion in revenue in the third quarter of 2019. Analysts also expect UnitedHealth to post adjusted EPS of $3.09 in the third quarter, which represents a significant fall year-over-year from $3.88.
UnitedHealth boasts an attractive earnings surprise history. The company’s adjusted EPS have beaten analysts' average estimates in each of the last four quarters, by an average of 11.6 percent.
What is UnitedHealth's stock price? And UnitedHealth's stock price in premarket trading today?
UnitedHealth stock is traded on the NYSE under the ticker symbol “UNH.” The stock was up about 0.01 percent at $330 in premarket trading today as of 4:19 a.m. ET. The stock rose 0.7 percent on Oct. 12 and closed at $329.97 with a market capitalization of $313.6 billion.
UnitedHealth stock has risen by 3.7 percent in the last five days and 49.6 percent in the last year. It's trading 1.1 percent below its 52-week high of $333.56 and 75.8 percent above its 52-week low of $187.72.
What is UnitedHealth’s dividend yield?
As of Oct. 12, UnitedHealth’s dividend yield was 1.52 percent. The company currently pays an annual dividend of $5 per share. UnitedHealth has increased its dividend for the last ten years.
What is UnitedHealth’s stock forecast?
Currently, analysts' stock price forecast for UnitedHealth is $346.20, which suggests a 4.9 percent upside. Their highest target price of $392 implies an 18.8 percent upside, while their lowest target price of $310 suggests a 6.1 percent downside. Of the 27 Wall Street analysts tracking UnitedHealth, 21 recommend "buy," and six recommend "hold." None of the analysts recommend "sell."
UnitedHealth investor relations
UnitedHealth has scheduled its third-quarter earnings conference call for Wednesday, Oct. 14 at 8:45 a.m. ET. Investors and analysts can access the teleconference through the investor relations section of the company’s website. A replay of the event will be available through Oct. 28 on the website or by dialing 1-800-839-5493.